Home
/ STERIS
/ Competitors

STERIS Competitors and Similar CompaniesClear all

STERIS's competitors and similar companies include Cantel Medical, Belimed and Stryker.

	STERIS STERIS is a company that provides infection prevention and procedural products and services.	Cantel Medical Cantel Medical is a company that provides infection prevention products and services for the healthcare market.	Belimed Belimed is a supplier of infection control products for medical and life science sectors.	Stryker Stryker is a medical technology company providing medical, surgical, neurotechnology, orthopedics, and spine solutions.
Founding Date	Founding Date 1985	Founding Date 1963	Founding Date 1990	Founding Date 1941
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare Manufacturing & Industrial dental medical devices medtech	Tags Healthcare healthtech medical devices medical diagnostics	Tags Healthcare medical devices	Tags Manufacturing & Industrial medical devices medtech surgical solutions
Locations	Locations Mentor, US HQ Watermael Boitsfort, BE São Paulo, BR Mississauga, CA Québec, CA Whitby, CA Suzhou, CN see more	Locations Little Falls, US HQ Heatherton, AU Richmond Hill, CA Shanghai, CN Toulouse, FR Düsseldorf, DE Gersthofen, DE see more	Locations Zug, CH HQ Feldkirchen Bei Graz, AT Chengdu Shi, CN Guangzhou Shi, CN Sausheim, FR see more	Locations Portage, US HQ Munro, AR St Leonards, AU Wien, AT Zaventem, BE São Paulo, BR London, CA see more
Employees	Employees 17,1004% increase	Employees 9251% decrease	Employees 6281% decrease	Employees 52,0002% increase
Valuation ($)	Valuation ($) 23.3 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 135 b
Financial
Revenue (est.)	Revenue (est.) $5.1b (FY, 2024)	Revenue (est.) $1b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) $20.5b (FY, 2023)
Cost of goods	Cost of goods $2.9b (FY, 2024)	Cost of goods $580.1m (FY, 2020)	Cost of goods N/A	Cost of goods $7.4b (FY, 2023)
Gross profit	Gross profit $2.2b (FY, 2024)	Gross profit $436m (FY, 2020)	Gross profit N/A	Gross profit $13.1b (FY, 2023)
Net income	Net income $380.1m (FY, 2024)	Net income $13.7m (FY, 2020)	Net income N/A	Net income $3.2b (FY, 2023)
Operating ⚠
Backlog	Backlog $534.4m (Q3, 2024)	Backlog 72.4 m (FY, 2016)	Backlog N/A	Backlog N/A
Trademarks	Trademarks 2.5 k (FY, 2023)	Trademarks 1.9 k (FY, 2016)	Trademarks N/A	Trademarks N/A